Literature DB >> 12657883

Neuronal accumulation of alpha- and beta-synucleins in the brain of a GM2 gangliosidosis mouse model.

Kyoko Suzuki1, Eizo Iseki, Omi Katsuse, Akira Yamaguchi, Kayoko Katsuyama, Ichiro Aoki, Shoji Yamanaka, Kenji Kosaka.   

Abstract

Sandhoff disease (SD) is a heritable lysosomal storage disease resulting from impaired degradation of GM2 ganglioside. The hallmark pathology of the SD model mouse brain is GM2 ganglioside accumulation in neurons. In the present study, we immunohistochemically investigated the neuronal pathology in SD mouse brains, and demonstrated neuronal accumulation of alpha- and beta-synucleins in addition to GM2 ganglioside. Synuclein-positive neurons were extensively observed throughout SD mouse brains, although the distribution of beta-synuclein was less extensive than that of alpha-synuclein. Synuclein-positive neurons were negative to ubiquitin and PHF-tau. These findings suggest that neuronal synucleins may accumulate secondarily to GM2 ganglioside in SD mouse brains, and that neuronal accumulation of synucleins may be more critical than that of GM2 ganglioside for SD mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657883     DOI: 10.1097/00001756-200303240-00004

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  26 in total

Review 1.  Biophysics of α-synuclein membrane interactions.

Authors:  Candace M Pfefferkorn; Zhiping Jiang; Jennifer C Lee
Journal:  Biochim Biophys Acta       Date:  2011-07-28

2.  Lessons learnt from animal models: pathophysiology of neuropathic lysosomal storage disorders.

Authors:  Kim M Hemsley; John J Hopwood
Journal:  J Inherit Metab Dis       Date:  2010-05-07       Impact factor: 4.982

3.  Decreased expression of lysosomal alpha-galactosiase A gene in sporadic Parkinson's disease.

Authors:  Guanghua Wu; Jian Huang; Xungang Feng; Aimei Zhang; Jifeng Li; Shuchao Pang; Kejin Gu; Haixin Dong; Junping Zhang; Huijie Gao; Bo Yan
Journal:  Neurochem Res       Date:  2011-06-05       Impact factor: 3.996

Review 4.  Defective Lysosomal Lipid Catabolism as a Common Pathogenic Mechanism for Dementia.

Authors:  Jun Yup Lee; Oana C Marian; Anthony S Don
Journal:  Neuromolecular Med       Date:  2021-02-07       Impact factor: 3.843

5.  Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse models.

Authors:  Y H Xu; Y Sun; H Ran; B Quinn; D Witte; G A Grabowski
Journal:  Mol Genet Metab       Date:  2010-12-31       Impact factor: 4.797

Review 6.  Modeling neuronopathic storage diseases with patient-derived culture systems.

Authors:  Friederike Zunke; Joseph R Mazzulli
Journal:  Neurobiol Dis       Date:  2019-02-19       Impact factor: 5.996

7.  p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy.

Authors:  Yun Ju C Song; Ditte M S Lundvig; Yue Huang; Wei Ping Gai; Peter C Blumbergs; Peter Højrup; Daniel Otzen; Glenda M Halliday; Poul H Jensen
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

Review 8.  Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?

Authors:  Masayo Fujita; Akio Sekigawa; Kazunari Sekiyama; Shuei Sugama; Makoto Hashimoto
Journal:  J Neurol       Date:  2009-08       Impact factor: 4.849

9.  Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein.

Authors:  Paula Desplats; He-Jin Lee; Eun-Jin Bae; Christina Patrick; Edward Rockenstein; Leslie Crews; Brian Spencer; Eliezer Masliah; Seung-Jae Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-27       Impact factor: 11.205

10.  Protective role of endogenous gangliosides for lysosomal pathology in a cellular model of synucleinopathies.

Authors:  Jianshe Wei; Masayo Fujita; Masaaki Nakai; Masaaki Waragai; Akio Sekigawa; Shuei Sugama; Takato Takenouchi; Eliezer Masliah; Makoto Hashimoto
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.